T1	intervention 0 15	Chemoprevention
T2	duration 375 405	from October 2014 to June 2017
T3	eligibility 342 374	Women seen in a high-risk clinic
T4	No-of-participants 747 751	1506
T5	outcome 853 882	likely to use chemoprevention
T6	outcome 938 972	Chemoprevention use by risk factor
T7	outcome 1266 1289	fear of adverse effects
